Zelira Archives - Green Market Report

Julie AitchesonSeptember 30, 2020


Autism is a developmental disorder characterized by communication and behavioral difficulties from minor to extremely severe. There is no medical cure for autism and much remains mysterious about the condition. There is no blood test or similarly straightforward means of diagnosis, and can often be missed for years or even a lifetime by a physician.  Autism can express differently in every individual, with a broad range of symptoms and gradients of severity that can make treating symptoms even more challenging than gaining a diagnosis. Conventional treatments for symptoms of ASD, which include a variety of drugs to relieve seizures or behavioral and anxiety issues, often come with serious side effects of their own. While interventions like cognitive behavioral therapy and speech-language therapy can have a positive impact on outcomes for those with ASD, those with more severe conditions may require some form of medication. Yet again, the adverse side effects that come with these medications create an untenable Catch-22 for ASD patients and caregivers alike. Enter HOPE.

HOPE tinctures are the creation of Zelira Therapeutics and Erica Daniels, founder of Hope Grows for Autism, a nonprofit aimed at improving the lives of families affected by autism through research, education, and advocacy of natural treatments. Daniels is a proud partner of Zelira Therapeutics, which formed through a merger of Zelda and Ilera Therapeutics in 2019. As the mother of a child with severe autism, Daniels responded to years of traveling the country in an exhaustive but fruitless search for treatments for her son by forging her own path, using diet and medical cannabis to ensure a high quality of life for her son and family.

Through partnerships within the state of Louisiana, HOPE tinctures (which are specifically formulated with Autism Spectrum Disorder in mind) will be available exclusively through state-licensed medical marijuana dispensaries in the state to all patients and families bearing a doctor’s prescription. The tinctures will be available in two formulations, “HOPE1”, which is a 1:1 THC: CBD tincture, and “HOPE2”, a 5:1 THC: CBD tincture. 

Louisiana ranks higher than the national average for the percentage of autism diagnoses per capita and recently passed legislation in the state allows all Louisiana patients and families to receive medical cannabis through a doctor’s prescription for any condition. This makes it a perfect staging ground for this new partnership between the HOPE line of medical cannabis tinctures, Lousiana’s Ilera Holistic Healthcare, and Southern University’s Agricultural Center, through which the tinctures are grown, cultivated, processed, and packaged. With the introduction of the specially formulated and research-based HOPE tinctures into medical marijuana dispensaries across Louisiana, Erica Daniels is excited to bring the benefits of cannabis to other constituents in the ASD community.

HOPE™ was formulated by Zelira Therapeutics a leading global therapeutic medical cannabis company with access to the world’s largest and fastest growing cannabis markets. The company’s focus is on developing branded cannabis products for the treatment of a variety of medical conditions including insomnia, autism and chronic non-cancer pain.


Julie AitchesonMay 12, 2020


It is not news that medical marijuana companies are constantly innovating to offer cannabis-derived products specifically formulated for those suffering from life-threatening and debilitating illnesses such as autism, cancer, and epilepsy. What doesn’t regularly make the headlines is the fact that many of them are creating and partnering with non-profit organizations in order to support providers and patients in turning that life-saving (or at least life-enhancing) corner. 

Hope Grows For Autisma nonprofit aimed at improving the lives of families affected by autism through research, education, and the advocacy of medical natural treatments was founded by Erica Daniels. Daniels is the mother of an autistic child, and her quest for a better quality of life for her son and family led her to discover the overwhelming significance of diet and medical cannabis in addressing her child’s autism. Her organization’s mission inspired a partnership between Hope Grows For Autism and medical marijuana company Zelira Therapeutics (formerly Zelda Therapeutics, which merged with Ilera Healthcare to form Zelira) in the creation of their HOPE™ range of products, which are formulated specifically for autism spectrum disorders. These products are olive oil-based tinctures that include Hope 1, which has a 1 to 1 THC:CBD ratio, and Hope 2, with a THC:CBD ratio of 5 to 1.  These formulas were created with the specific challenges of autism in mind, and have become bestselling items for Zelira.

Then there is The Flowering HOPE Foundation, a non-profit started by Jason Cranford, founder of medical marijuana company Haleigh’s Hope. The Flowering HOPE Foundation facilitates safe, lawful access to medical marijuana for individuals suffering from multiple ailments including Crohn’s, cancer, and epilepsy. Flowering HOPE also participates in petitioning and lobbying for clearer regulatory guidelines around marijuana access and use, such as this case profiled by PR Newswire involving a challenge of the DEA’s classification of hemp oil and CBD products as Schedule 1 substances. 

No profile of medical marijuana companies flexing philanthropic muscle on behalf of those in need would be complete without a mention of Colorado flagship company, Charlotte’s Web. Charlotte’s Web enjoys an active partnership with the Realm of Caring Foundation, a non-profit that provides education for patients and healthcare providers, research, and support to families in need of access to medical marijuana. The organization seeks to build a supportive community among those benefiting from the use of medical marijuana in their healing protocols and providing the latest research to inform decisions about treatment. 

This community-building aspect, which all of the aforementioned non-profits share, is particularly valuable to families who do not find the support they need for their medical marijuana treatment protocols from health insurance companies and the larger medical community.  As the science of crafting highly targeted formulas for some of today’s most challenging medical conditions becomes ever more refined, it is both evident and encouraging that some of the industry’s leading medical marijuana companies remain committed to serving the people behind the profits.


Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up

About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


Recent Tweets

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.